Back to search

Article

Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer’s Disease

2019-04-29

Abstract excerpt

<h4>Background</h4> A significant number of studies have investigated the use of blood-derived gene expression profiling as a biomarker for Alzheimer’s Disease (AD). However, the typical approach of developing classification models trained on subjects with AD and complimentary cognitive healthy controls may result in markers of general illness rather than being AD-specific. Incorporating additional related neurol...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c7c8cd44-44e4-54af-b1c4-b4970c8607c4
DOI
10.1101/621987
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Working Towards a Blood-Derived Gene Expression Biomarker Specific for Alzheimer’s DiseaseDOI 10.1101/621987
Prediction of Alzheimer’s disease using blood gene expression dataSemantic proximity
Toward an Alzheimer's disease diagnosis via high‐resolution blood gene expressionSemantic proximity
Blood-Based RNA Biomarkers and Machine Learning Approaches for Alzheimer’s DiseaseSemantic proximity
Blood biomarker-based classification study for neurodegenerative diseasesSemantic proximity
A Gene Expression Pattern in Blood for the Early Detection of Alzheimer's DiseaseSemantic proximity
A Blood Gene Expression Marker of Early Alzheimer's DiseaseSemantic proximity
Analysis of Blood Gene Expression Data Toward Early Detection of Alzheimer’s DiseaseSemantic proximity
Validation of AclarusDx™, a Blood-Based Transcriptomic Signature for the Diagnosis of Alzheimer's DiseaseSemantic proximity
Integrative Transcriptomics and Machine Learning Reveal a Robust Biomarker Signature for Alzheimer’s DiseaseSemantic proximity
Using blood transcriptome analysis for Alzheimer's disease diagnosis and patient stratificationSemantic proximity
A transcriptome-wide association study identifies novel blood-based gene biomarker candidates for Alzheimer's disease risk.Semantic proximity
Identification of common molecular biomarker signatures in blood and brain of Alzheimer’s diseaseSemantic proximity
Select a neighboring publication to make it the new centre.